†<p>All patients included in this study were asked whether their living or dead first-degree relatives (parents, siblings, children) had been affected by a lung malignancy.</p>‡<p>P<0.05 and P<0.01 are set for significant and highly significant difference, respectively.</p
Lung adenocarcinoma patients of similar clinical stage and undergoing the same treatments often have...
Lung adenocarcinoma patients of similar clinical stage and undergoing the same treatments often have...
Lung adenocarcinoma patients of similar clinical stage and undergoing the same treatments often have...
†<p>All patients included in this study were asked whether their living or dead first-degree relativ...
BackgroundCCN family, comprising six members (Cyr61, CTGF, Nov, WISP-1, WISP-2, WISP-3), is involved...
BackgroundCCN family, comprising six members (Cyr61, CTGF, Nov, WISP-1, WISP-2, WISP-3), is involved...
BackgroundCCN family, comprising six members (Cyr61, CTGF, Nov, WISP-1, WISP-2, WISP-3), is involved...
CCN family, comprising six members (Cyr61, CTGF, Nov, WISP-1, WISP-2, WISP-3), is involved in the st...
CCN family, comprising six members (Cyr61, CTGF, Nov, WISP-1, WISP-2, WISP-3), is involved in the st...
BACKGROUND:In lung cancer, a patient's survival is poor with a wide variation in survival within the...
<p>Relative mRNA expression levels of <i>Cyr61</i>, <i>CTGF</i>, and <i>WISP-1</i> are shown in 60 p...
Background: In lung cancer, a patient’s survival is poor with a wide variation in survival within th...
In lung cancer, a patient's survival is poor with a wide variation in survival within the stage of d...
<p>The graph depict distributions of specimens according to the percentage of cells positive for Cyr...
<p>In non-cancerous lung tissues from patients with NSCLC, intense Cyr61 immunoreactivity (brown) is...
Lung adenocarcinoma patients of similar clinical stage and undergoing the same treatments often have...
Lung adenocarcinoma patients of similar clinical stage and undergoing the same treatments often have...
Lung adenocarcinoma patients of similar clinical stage and undergoing the same treatments often have...
†<p>All patients included in this study were asked whether their living or dead first-degree relativ...
BackgroundCCN family, comprising six members (Cyr61, CTGF, Nov, WISP-1, WISP-2, WISP-3), is involved...
BackgroundCCN family, comprising six members (Cyr61, CTGF, Nov, WISP-1, WISP-2, WISP-3), is involved...
BackgroundCCN family, comprising six members (Cyr61, CTGF, Nov, WISP-1, WISP-2, WISP-3), is involved...
CCN family, comprising six members (Cyr61, CTGF, Nov, WISP-1, WISP-2, WISP-3), is involved in the st...
CCN family, comprising six members (Cyr61, CTGF, Nov, WISP-1, WISP-2, WISP-3), is involved in the st...
BACKGROUND:In lung cancer, a patient's survival is poor with a wide variation in survival within the...
<p>Relative mRNA expression levels of <i>Cyr61</i>, <i>CTGF</i>, and <i>WISP-1</i> are shown in 60 p...
Background: In lung cancer, a patient’s survival is poor with a wide variation in survival within th...
In lung cancer, a patient's survival is poor with a wide variation in survival within the stage of d...
<p>The graph depict distributions of specimens according to the percentage of cells positive for Cyr...
<p>In non-cancerous lung tissues from patients with NSCLC, intense Cyr61 immunoreactivity (brown) is...
Lung adenocarcinoma patients of similar clinical stage and undergoing the same treatments often have...
Lung adenocarcinoma patients of similar clinical stage and undergoing the same treatments often have...
Lung adenocarcinoma patients of similar clinical stage and undergoing the same treatments often have...